SlideShare una empresa de Scribd logo
1 de 118
Archer online USMLE reviews www.ccsworkshop.com   All Rights reserved Archer Slides are intended for use with Archer USMLE step 3 video lectures. Hence, most  slides are very brief summaries of the concepts which will be addressed in a detailed way with focus on High-yield concepts in the Video lectures.  These slides are only SAMPLES
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Table 1: Hemodynamic effects of IABP Therapy
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
 
 
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
 
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
 
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object]
The PR interval is 388 ms and constant. Each P wave is followed by a QRS complex.
Note the progressive lengthening of the PR interval until a P wave is blocked. The PR interval following the blocked P wave is shorter than the one before the blocked P wave. Progressive shortening of the R-R interval is best shown in the 5:4 cycle on the right of the strip
P waves are blocked intermittently. The PR interval does not change. Note the wide QRS complexes.
No relationship between the atrial and ventricular activity is present. The atrial rhythm is sinus at 90 beats/min. A slight sinus arrhythmia is present. The ventricular rhythm is a wide QRS escape rhythm at 26 beats/min.
Test Notes ECG with rhythm strip Essential to define the type and site of the block.  Echocardiogram Useful to determine the presence and severity of structural heart disease     evidence of previous MI, hypertensive heart disease, valvular heart disease, and infective endocarditis. Transesophageal echocardiogram is superior to transthoracic echocardiogram in identifying aortic root abscesses and infections involving prosthetic heart valves Serum electrolytes To evaluate for hyperkalemia, especially in patients with kidney disease Cardiac enzymes (creatine kinase, cardiac troponin) Can identify ischemia/infarction or myocarditis as potential causes of AV block Lyme serology Can identify Lyme disease as a potential cause of AV block Serum digoxin level Can identify digitalis toxicity as a potential cause of AV block Thyroid function tests To evaluate for hypothyroidism Blood cultures To evaluate for evidence of bacteremia and possible infective endocarditis ( ? New onset heart block, bbb)
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object]
[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
 
[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object]
Class Procedures – High Risk Antibiotic regimens Dental Routine cleaning Tooth extraction Periodontal procedures Dental implant placement Reimplantation of avulsed teeth Endodontic instrumentation (root canal) ,[object Object],[object Object],[object Object],[object Object],[object Object],Pulmonary Rigid bronchoscopy, Surgical operations that involve respiratory mucosa Same as for dental procedures
[object Object],[object Object]
An IV drug abuser who recently survived an infective endocarditis episode come to you and says that she cannot give up IVDA but requests you for prophylaxis because she is  a high risk for IE as she continues to inject herself putting herself at a risk for bacteremia   what would you do??
[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
 
[object Object],[object Object]
Lifestyle Modification Approximate SBP Reduction Weight Reduction 5 to 10 mm Hg for every 10kg weight reduction DASH Diet 8 to 14 mm Hg Dietary Sodium Restriction 2 to 8 mm Hg Physical activity 4 to 9 mm hg Moderation of alcohol use 2 to 4 mm hg
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
 
 
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
END!

Más contenido relacionado

Destacado

Blood components preparation and therapeutic uses final
Blood components preparation and therapeutic uses finalBlood components preparation and therapeutic uses final
Blood components preparation and therapeutic uses final
globalsoin
 

Destacado (16)

Archer Dermatology USMLE step 3
Archer Dermatology USMLE step 3Archer Dermatology USMLE step 3
Archer Dermatology USMLE step 3
 
Plasma cell disorders ppt
Plasma cell disorders pptPlasma cell disorders ppt
Plasma cell disorders ppt
 
Production as strategy
Production as strategyProduction as strategy
Production as strategy
 
Bleaching, textile treatment
Bleaching, textile treatmentBleaching, textile treatment
Bleaching, textile treatment
 
Net Promoter Score - A 10 Slide Introduction
Net Promoter Score - A 10 Slide IntroductionNet Promoter Score - A 10 Slide Introduction
Net Promoter Score - A 10 Slide Introduction
 
PHP and Web Services
PHP and Web ServicesPHP and Web Services
PHP and Web Services
 
Developing Real-Time Data Pipelines with Apache Kafka
Developing Real-Time Data Pipelines with Apache KafkaDeveloping Real-Time Data Pipelines with Apache Kafka
Developing Real-Time Data Pipelines with Apache Kafka
 
Digital content trends 2013
Digital content trends 2013Digital content trends 2013
Digital content trends 2013
 
SBM Latest trend in School Management
SBM Latest trend in School ManagementSBM Latest trend in School Management
SBM Latest trend in School Management
 
A good ppt on Clinical congenital heart disease for Post Graduate
A good ppt on Clinical congenital heart disease for Post GraduateA good ppt on Clinical congenital heart disease for Post Graduate
A good ppt on Clinical congenital heart disease for Post Graduate
 
Integration of metabolism
Integration of metabolismIntegration of metabolism
Integration of metabolism
 
Scientific Method Variables (Teach)
Scientific Method Variables (Teach)Scientific Method Variables (Teach)
Scientific Method Variables (Teach)
 
Mughal empire
Mughal empireMughal empire
Mughal empire
 
Lighting you up in Battlefield 3
Lighting you up in Battlefield 3Lighting you up in Battlefield 3
Lighting you up in Battlefield 3
 
Blood components preparation and therapeutic uses final
Blood components preparation and therapeutic uses finalBlood components preparation and therapeutic uses final
Blood components preparation and therapeutic uses final
 
Building maintenance
Building maintenanceBuilding maintenance
Building maintenance
 

Más de Archer Review USMLE and NCLEX

Más de Archer Review USMLE and NCLEX (20)

Endocrine Archer NCLEX course Webinar
Endocrine Archer NCLEX course WebinarEndocrine Archer NCLEX course Webinar
Endocrine Archer NCLEX course Webinar
 
Safety and infection control - Archer NCLEX webinars
Safety and infection control - Archer NCLEX webinarsSafety and infection control - Archer NCLEX webinars
Safety and infection control - Archer NCLEX webinars
 
Archer NCLEX Webinars - Diets and Nutrition crash course
Archer NCLEX Webinars - Diets and Nutrition crash courseArcher NCLEX Webinars - Diets and Nutrition crash course
Archer NCLEX Webinars - Diets and Nutrition crash course
 
Rapid Content Prep - NCLEX- Archer Review
Rapid Content Prep - NCLEX- Archer ReviewRapid Content Prep - NCLEX- Archer Review
Rapid Content Prep - NCLEX- Archer Review
 
Archer NCLEX Rapid Review - Full Content Syllabus - Two days
Archer NCLEX Rapid Review - Full Content Syllabus - Two daysArcher NCLEX Rapid Review - Full Content Syllabus - Two days
Archer NCLEX Rapid Review - Full Content Syllabus - Two days
 
Cardiology and EKGs - Archer NCLEX crash course/ webinar
Cardiology and EKGs - Archer NCLEX crash course/ webinarCardiology and EKGs - Archer NCLEX crash course/ webinar
Cardiology and EKGs - Archer NCLEX crash course/ webinar
 
Fluids and electrolytes Archer NCLEX content review webinar
Fluids and electrolytes  Archer NCLEX content review webinarFluids and electrolytes  Archer NCLEX content review webinar
Fluids and electrolytes Archer NCLEX content review webinar
 
Archer NCLEX Pharmacology crash course - Webinar
Archer NCLEX Pharmacology crash course - WebinarArcher NCLEX Pharmacology crash course - Webinar
Archer NCLEX Pharmacology crash course - Webinar
 
Archer NCLEX Review - Electrolyte imbalances
Archer NCLEX Review - Electrolyte imbalancesArcher NCLEX Review - Electrolyte imbalances
Archer NCLEX Review - Electrolyte imbalances
 
Archer USMLE Step 3 Nephrology 2019
Archer USMLE Step 3 Nephrology 2019Archer USMLE Step 3 Nephrology 2019
Archer USMLE Step 3 Nephrology 2019
 
Pulmonology critical care- archer step3 lectures
Pulmonology  critical care- archer step3 lecturesPulmonology  critical care- archer step3 lectures
Pulmonology critical care- archer step3 lectures
 
Endocrinology archer step3 lectures
Endocrinology   archer step3 lecturesEndocrinology   archer step3 lectures
Endocrinology archer step3 lectures
 
Infectious disease Archer USMLE Step3 Review Lectures
Infectious disease   Archer USMLE Step3 Review LecturesInfectious disease   Archer USMLE Step3 Review Lectures
Infectious disease Archer USMLE Step3 Review Lectures
 
Archer step 3 ccs workshop 2019
Archer step 3 ccs workshop 2019Archer step 3 ccs workshop 2019
Archer step 3 ccs workshop 2019
 
Cutaneous lymphomas
Cutaneous lymphomasCutaneous lymphomas
Cutaneous lymphomas
 
Acute Lymphoblastic Lymphoma
Acute Lymphoblastic LymphomaAcute Lymphoblastic Lymphoma
Acute Lymphoblastic Lymphoma
 
Carcinoma of unknown primary
Carcinoma of unknown primaryCarcinoma of unknown primary
Carcinoma of unknown primary
 
Bladder cancer
Bladder cancerBladder cancer
Bladder cancer
 
Thrombophilias
ThrombophiliasThrombophilias
Thrombophilias
 
Thrombocytopenia
ThrombocytopeniaThrombocytopenia
Thrombocytopenia
 

Último

Beyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactBeyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global Impact
PECB
 
1029-Danh muc Sach Giao Khoa khoi 6.pdf
1029-Danh muc Sach Giao Khoa khoi  6.pdf1029-Danh muc Sach Giao Khoa khoi  6.pdf
1029-Danh muc Sach Giao Khoa khoi 6.pdf
QucHHunhnh
 
The basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptxThe basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptx
heathfieldcps1
 

Último (20)

Micro-Scholarship, What it is, How can it help me.pdf
Micro-Scholarship, What it is, How can it help me.pdfMicro-Scholarship, What it is, How can it help me.pdf
Micro-Scholarship, What it is, How can it help me.pdf
 
Food Chain and Food Web (Ecosystem) EVS, B. Pharmacy 1st Year, Sem-II
Food Chain and Food Web (Ecosystem) EVS, B. Pharmacy 1st Year, Sem-IIFood Chain and Food Web (Ecosystem) EVS, B. Pharmacy 1st Year, Sem-II
Food Chain and Food Web (Ecosystem) EVS, B. Pharmacy 1st Year, Sem-II
 
Beyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactBeyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global Impact
 
Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17
 
Holdier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdfHoldier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdf
 
1029-Danh muc Sach Giao Khoa khoi 6.pdf
1029-Danh muc Sach Giao Khoa khoi  6.pdf1029-Danh muc Sach Giao Khoa khoi  6.pdf
1029-Danh muc Sach Giao Khoa khoi 6.pdf
 
Application orientated numerical on hev.ppt
Application orientated numerical on hev.pptApplication orientated numerical on hev.ppt
Application orientated numerical on hev.ppt
 
The basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptxThe basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptx
 
Introduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The BasicsIntroduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The Basics
 
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
 
2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx
2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx
2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx
 
How to Give a Domain for a Field in Odoo 17
How to Give a Domain for a Field in Odoo 17How to Give a Domain for a Field in Odoo 17
How to Give a Domain for a Field in Odoo 17
 
ComPTIA Overview | Comptia Security+ Book SY0-701
ComPTIA Overview | Comptia Security+ Book SY0-701ComPTIA Overview | Comptia Security+ Book SY0-701
ComPTIA Overview | Comptia Security+ Book SY0-701
 
ICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptxICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptx
 
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
 
Key note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdfKey note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdf
 
Python Notes for mca i year students osmania university.docx
Python Notes for mca i year students osmania university.docxPython Notes for mca i year students osmania university.docx
Python Notes for mca i year students osmania university.docx
 
Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024
 
Sociology 101 Demonstration of Learning Exhibit
Sociology 101 Demonstration of Learning ExhibitSociology 101 Demonstration of Learning Exhibit
Sociology 101 Demonstration of Learning Exhibit
 
Mixin Classes in Odoo 17 How to Extend Models Using Mixin Classes
Mixin Classes in Odoo 17  How to Extend Models Using Mixin ClassesMixin Classes in Odoo 17  How to Extend Models Using Mixin Classes
Mixin Classes in Odoo 17 How to Extend Models Using Mixin Classes
 

Cardiology[2] - Archer USMLE step 3

  • 1. Archer online USMLE reviews www.ccsworkshop.com All Rights reserved Archer Slides are intended for use with Archer USMLE step 3 video lectures. Hence, most slides are very brief summaries of the concepts which will be addressed in a detailed way with focus on High-yield concepts in the Video lectures. These slides are only SAMPLES
  • 2.
  • 3.
  • 4.
  • 5.
  • 6. Table 1: Hemodynamic effects of IABP Therapy
  • 7.
  • 8.
  • 9.
  • 10.
  • 11.
  • 12.
  • 13.
  • 14.  
  • 15.  
  • 16.
  • 17.
  • 18.
  • 19.
  • 20.
  • 21.
  • 22.
  • 23.
  • 24.
  • 25.
  • 26.
  • 27.
  • 28.
  • 29.  
  • 30.
  • 31.
  • 32.
  • 33.
  • 34.
  • 35.
  • 36.
  • 37.  
  • 38.
  • 39.
  • 40.
  • 41.
  • 42. The PR interval is 388 ms and constant. Each P wave is followed by a QRS complex.
  • 43. Note the progressive lengthening of the PR interval until a P wave is blocked. The PR interval following the blocked P wave is shorter than the one before the blocked P wave. Progressive shortening of the R-R interval is best shown in the 5:4 cycle on the right of the strip
  • 44. P waves are blocked intermittently. The PR interval does not change. Note the wide QRS complexes.
  • 45. No relationship between the atrial and ventricular activity is present. The atrial rhythm is sinus at 90 beats/min. A slight sinus arrhythmia is present. The ventricular rhythm is a wide QRS escape rhythm at 26 beats/min.
  • 46. Test Notes ECG with rhythm strip Essential to define the type and site of the block. Echocardiogram Useful to determine the presence and severity of structural heart disease  evidence of previous MI, hypertensive heart disease, valvular heart disease, and infective endocarditis. Transesophageal echocardiogram is superior to transthoracic echocardiogram in identifying aortic root abscesses and infections involving prosthetic heart valves Serum electrolytes To evaluate for hyperkalemia, especially in patients with kidney disease Cardiac enzymes (creatine kinase, cardiac troponin) Can identify ischemia/infarction or myocarditis as potential causes of AV block Lyme serology Can identify Lyme disease as a potential cause of AV block Serum digoxin level Can identify digitalis toxicity as a potential cause of AV block Thyroid function tests To evaluate for hypothyroidism Blood cultures To evaluate for evidence of bacteremia and possible infective endocarditis ( ? New onset heart block, bbb)
  • 47.
  • 48.
  • 49.
  • 50.
  • 51.
  • 52.
  • 53.
  • 54.
  • 55.
  • 56.
  • 57.
  • 58.
  • 59.
  • 60.
  • 61.
  • 62.
  • 63.
  • 64.
  • 65.
  • 66.
  • 67.
  • 68.
  • 69.
  • 70.
  • 71.
  • 72.
  • 73.
  • 74.
  • 75.  
  • 76.
  • 77.
  • 78.
  • 79.
  • 80.
  • 81.
  • 82.
  • 83.
  • 84.
  • 85.
  • 86. An IV drug abuser who recently survived an infective endocarditis episode come to you and says that she cannot give up IVDA but requests you for prophylaxis because she is a high risk for IE as she continues to inject herself putting herself at a risk for bacteremia  what would you do??
  • 87.
  • 88.
  • 89.
  • 90.
  • 91.
  • 92.  
  • 93.
  • 94. Lifestyle Modification Approximate SBP Reduction Weight Reduction 5 to 10 mm Hg for every 10kg weight reduction DASH Diet 8 to 14 mm Hg Dietary Sodium Restriction 2 to 8 mm Hg Physical activity 4 to 9 mm hg Moderation of alcohol use 2 to 4 mm hg
  • 95.
  • 96.
  • 97.
  • 98.  
  • 99.  
  • 100.
  • 101.
  • 102.
  • 103.
  • 104.
  • 105.
  • 106.
  • 107.
  • 108.
  • 109.
  • 110.
  • 111.
  • 112.
  • 113.
  • 114.
  • 115.
  • 116.
  • 117.
  • 118. END!